ArticleTherapeutic advances in medical oncology2023

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.

Li-Na He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.